Filtering by:
Basal and Squamous Cell Skin CancerTop Story
October 8, 2018
FDA Approves Libtayo (Cemiplimab) for a Type of Skin Cancer
The US Food and Drug Administration (FDA) has approved Libtayo (cemiplimab) to treat people with advanced squamous cell carcinoma of the skin.
May 14, 2015
Skin Cancer Survivor Says, ‘Love the skin you’re in.’
Skin cancer survivor Cathey Gray has not seen the inside of a tanning bed since last summer. Before that, for about 7 years, she tanned her skin in a tanning bed almost every day.